drugset / Trial / NCT03446976
CT-P13 (Infliximab) Subcutaneous Administration by Pre-filled Syringe and Auto-injector in Healthy Subjects
RandomizedParallel-groupOpen-labelOther
Summary
This study compares two administration methods of CT-P13. Half of participants will receive CT-P13 by pre-filled syringe while the other half will receive CT-P13 by auto-injector.
Timeline
- Start
- 2018-02-21
- Primary completion
- 2018-07-26
- Completion
- 2018-07-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Infliximab | Monoclonal antibody | — | Subcutaneous |
Indications
No indication recorded.